Especialidad
Retina y Vítreo
Título completo
A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane versus Lucentis in Patients with Neovascular Age-Related Macular Degeneration
Promotor
Xbrane Biopharma
Fecha de inicio
Junio 2019
Investigadores
Principal: Dra Anniken Burés
Co-Investigadores: Dr. Rafael Navarro, Dr. Borja Corcóstegui, Dr. Carlos Mateo, Dra. Cecilia Salinas
